Comparative Study of Compliance between Sofosbuvir and Interferon in the Management of Viral Hepatitis at Tertiary Care Hospital of Gambat, Sindh, Pakistan
Sajid Ali
Department of Pharmacy, Shah Abdul Latif University (SALU), Khairpur, Sindh, Pakistan.
Zuheeb Ahmed
Department of Pharmacy, Shah Abdul Latif University (SALU), Khairpur, Sindh, Pakistan.
Marvi Metlo
Department of Pharmacy, Shah Abdul Latif University (SALU), Khairpur, Sindh, Pakistan.
Tahseen Ahmed
Institute of Pharmaceutical Sciences, People’s University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Sindh, Pakistan.
Shahzad Ali
Department of Pharmacy, Shah Abdul Latif University (SALU), Khairpur, Sindh, Pakistan.
Arslan Ahmer *
Institute of Pharmaceutical Sciences, People’s University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Sindh, Pakistan.
Muhammad Murtaza Qureshi
Institute of Pharmaceutical Sciences, People’s University of Medical and Health Sciences for Women (PUMHSW), Nawabshah, Sindh, Pakistan.
Syed Adeel Ahmed Shah
Department of Pharmaceutics, Faculty of Pharmacy, University of Sindh, Jamshoro, Pakistan.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Hepatitis can be defined as inflammation of the liver. Hepatitis may be acute or chronic. It is estimated that in 2017, approximately 15 million people suffered from Hepatitis in Pakistan suffering from hepatitis. 150–200 million people, or approximately ~3% of the world's population, are living with chronic Hepatitis C.
Methodology: A descriptive cross-sectional study was conducted on 300 patients selected by purposive sampling who were reported with Hepatitis-C and co infection of Hepatitis-C + Hepatitis-B, at a tertiary care hospital Gambat. A series of questions were asked from reported patients regarding symptoms and compliance.
Results: The results were analyzed by using SPSS-22. Among the 300 patients some were on sofosbuvir (n=150, 50%), which the others were on interferon (n=150, 50%). The findings showed that most of the patients on interferon were non-compliant (n=125,83.3%), and only (n=25, 16.7%) are compliant. Among non-compliant factors, fear from injection was reported in (n=42, 33.6), technique for injection (n=38, 30.4%), prolong duration of action (n=35, 28%), adverse drug reaction (n=26, 20.8%). Better compliance was observed with sofosbuvir (n=93, 62.8%) and non-compliant were (57, 38%).
Conclusion: This study concluded that better compliance was achieved with sofosbuvir as compared to interferon, rate of ADR’S were also less with sofosbuvir.
Keywords: Compliance, hepatitis, interferon, sofosbuvir